PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
-17.85%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$147M
AUM Growth
+$147M
(-35%)
Cap. Flow
-$13.6M
Cap. Flow
% of AUM
-9.26%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
TRVN
Trevena, Inc.
TRVN
|
$11.4M |
| 2 |
TTOO
T2 Biosystems, Inc
TTOO
|
$2.2M |
Sector Composition
| 1 | Healthcare | 81.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRVN
1
DELISTED
Trevena, Inc.
TRVN
| $27.6M | 18.82% |
2,669,280
-1,100,000
| -29% | -$11.4M |
|
|
ATYR
2
aTyr Pharma
ATYR
$527M
| $18.8M | 12.78% |
1,827,992
| – | – |
|
3
Pulmatrix
PULM
$18M
| $17.7M | 12.07% |
3,607,996
| – | – |
|
|
TTOO
4
DELISTED
T2 Biosystems, Inc
TTOO
| $17.7M | 12.05% |
2,018,450
-251,128
| -11% | -$2.2M |
|
5
Ocular Therapeutix
OCUL
$2.12B
| $17.3M | 11.78% |
1,230,009
| – | – |
|
|
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
| $13.5M | 9.19% |
1,968,606
| – | – |
|
7
Fate Therapeutics
FATE
$120M
| $13.2M | 8.98% |
2,473,186
| – | – |
|
8
Dare Bioscience
DARE
$27.2M
| $12M | 8.2% |
3,287,529
| – | – |
|
|
BIND
9
DELISTED
BIND THERAPEUTICS INC
BIND
| $9M | 6.13% |
2,018,253
| – | – |
|